IQVIA: Record Drug Approvals Highlight Growing Importance in the Age of AI

For me, the strategic significance of IQVIA Holdings (IQV, i) is clearly increasing in the age of AI. The company sits at an important intersection of drug development with its health data, clinical research services, and regulatory expertise – from study planning to marketing. With Predictive Clinical Development, AI is expected to significantly accelerate study starts and data analyses. According to IQVIA, pharmaceutical companies can save up to two years on a typical ten-year development program. An accordingly earlier market launch can be...